# MDClone

> MDClone is a healthcare data company that lets clinicians, researchers, and analysts explore patient data without touching real patient records. Its ADAMS platform ingests structured and unstructured health-system data into a longitudinal database, then generates statistically faithful synthetic data that carries no risk to patient privacy. That combination turns months-long, IRB-heavy data requests into self-service exploration, letting front-line staff ask their own questions, run analyses, and share results across organizations. Founded in Israel in 2016 and used across the U.S., Canada, and 100% of the Israeli healthcare market, MDClone has raised roughly $112M to expand data-driven discovery in health systems, government, payers, and life sciences.

- **Founded:** 2016
- **Headquarters:** Be'er Sheva, Israel
- **Founders:** Ziv Ofek (Co-founder & CEO), Luz Erez (Co-founder & CTO), Boaz Gur-Lavie (Co-founder & CFO)
- **Team size:** ~150 employees
- **Products:** ADAMS Healthcare Data Platform, Synthetic Data Engine, Longitudinal Database, Synthetic Data Platform for Life Science RWE Collaboration
- **Notable:** Developed what it describes as the first healthcare synthetic data engine., Named a 2021 Technology Pioneer by the World Economic Forum., Won MedTech Breakthrough Award for Best Healthcare Big Data Platform in 2021, 2022, and 2023.

## Products & services

- **ADAMS Healthcare Data Platform** — A self-service platform for data exploration, analysis, and action, giving clinicians, researchers, and analysts direct access to organizational data and tools to run their own investigations.
- **Synthetic Data Engine** — The core technology that scans original patient data and generates a statistically identical synthetic copy containing no real personal details, so it can be analyzed like real data with zero privacy risk.
- **Longitudinal Database** — Ingests and harmonizes structured and unstructured health-system data over time into a unified, query-ready store powering exploration and research.
- **Synthetic Data Platform for Life Science RWE Collaboration** — Lets health systems and life science companies collaborate on real-world evidence projects by sharing synthetic data across organizations.

## Achievements

- Developed what it describes as the first healthcare synthetic data engine.
- Named a 2021 Technology Pioneer by the World Economic Forum.
- Won MedTech Breakthrough Award for Best Healthcare Big Data Platform in 2021, 2022, and 2023.
- Ranked No. 1 quality, diagnosis, and treatment data platform for health systems in the 2023 Black Book Awards.
- Recognized among Modern Healthcare's Best in Business (2024).
- Adopted across 100% of the Israeli healthcare market.
- Raised approximately $112M in total funding.

## Latest updates

- **2024-09** — Appointed healthcare technology leader Bruno Lempernesse as President of North America to drive growth in the region.
- **2024** — Recognized as one of Modern Healthcare's Best in Business.
- **2023** — Launched deeper provider/life-sciences collaboration for therapeutic R&D via its synthetic data platform; named Black Book's No. 1 data platform for health systems.
- **2022-05** — Launched a synthetic data platform for life science real-world evidence (RWE) project collaboration.
- **2022-03** — Closed a $63M Series C round.

## Links

- Website: https://mdclone.com
- LinkedIn: https://www.linkedin.com/company/mdclone
- Twitter/X: https://twitter.com/MDClone_
- YouTube: https://www.youtube.com/@mdclone
- Facebook: https://facebook.com/MDClone-1043808662387015/

---

Profile page: https://yespress.io/mdclone
Published by YesPress — https://yespress.io
Last updated: 2026-07-19